FFAR4 and acute kidney injury: In conclusion, our study highlights that FFAR4 regulates cellular senescence via AMPK/SirT3 signaling in cisplatin-induced AKI, providing robust evidence that FFAR4 might as a promising target for the treatment of AKI.